GlassScriptAzur Cx Detachable
Payments companies reported to CMS as associated with Azur Cx Detachable. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Azur Cx Detachable, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Azur Cx Detachable
These are the largest totals companies reported as associated with Azur Cx Detachable. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Edward Lee | Los Angeles, CA | Vascular & Interventional Radiology | $284,196.63 |
| Navid Eghbalieh | Los Angeles, CA | Vascular & Interventional Radiology | $128,402.55 |
| Jessica Stewart | Los Angeles, CA | Vascular & Interventional Radiology | $113,216.95 |
| Erin Moore | Jacksonville, FL | Vascular Surgery | $44,571.22 |
| Eric Wang | Charlotte, NC | Diagnostic Radiology | $30,416.47 |
| Jeremy Kim | Charlotte, NC | Vascular & Interventional Radiology | $25,190.48 |
| Mark Lessne | Charlotte, NC | Diagnostic Radiology | $23,120.82 |
| Marcelo Guimaraes | Charleston, SC | Vascular & Interventional Radiology | $22,399.00 |
| Justin Mcwilliams | Los Angeles, CA | Vascular & Interventional Radiology | $22,292.10 |
| Andrew Hines | Charlotte, NC | Diagnostic Radiology | $22,119.28 |
Prescribed Azur Cx Detachable?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.